BUZZ - Amgen raises 2026 profit and revenue forecasts; shares fall

November 3 - ** Pharmaceutical company Amgen AMGN.O shares fell 2.2% in after-hours trading to $455.60

** The company (link) raised its adjusted earnings forecast for 2026 to $22.90 to $23.70 per share, up from a previous forecast of $22.30 to $23.50 per share

** Raised its annual revenue forecast to $38.9 billion to $39.7 billion from the prior estimate of $38.2 billion to $39.4 billion

** Third-quarter revenue was $10.4 billion, higher than analysts' expectations of $10.1 billion — according to LSEG data

** The report showed adjusted earnings per share this quarter were $6.45, above the expected $5.79

** As of the previous session's close, the stock had gained 40.9% so far this year

(To assist non-English speakers, Reuters has automated the translation of its reports into several other languages. Since automated translations may contain errors or lack context, Reuters does not guarantee the accuracy of the translated text, which is provided for readers' convenience only. Reuters is not liable for any damage or loss caused by the use of automated translation.)